儿童院内心搏骤停中肾上腺素给药间隔与生存结局的关系
该回顾性研究利用美国心脏协会Get With The Guidelines-Resuscitation登记数据,纳入1630例符合标准的儿童院内心搏骤停,按首次肾上腺素后复苏时长除以总剂量计算平均给药间隔,分为1-5分钟、>5至<8分钟、8至<10分钟/剂三组,主要终点为出院生存。以1-5分钟/剂为参照,全队列调整OR在>5至<8分钟组为1.81(95%CI 1.26-2.59),8至<10分钟组为2.64(95%CI 1.53-4.55)。在未使用血管活性药物输注的患者中,相应调整OR分别为1.99(95%CI 1.29-3.06)和2.67(95%CI 1.14-5.04)。作者结论认为,长于现行推荐的平均给药间隔与出院生存改善相关。
要点
- 全队列以1-5分钟/剂为参照,>5至<8分钟/剂出院生存调整OR 1.81(95%CI 1.26-2.59),8至<10分钟/剂调整OR 2.64(95%CI 1.53-4.55)。
- 未使用血管活性药物输注者中,>5至<8分钟/剂调整OR 1.99(95%CI 1.29-3.06),8至<10分钟/剂调整OR 2.67(95%CI 1.14-5.04)。
- 平均给药间隔定义为首次肾上腺素后复苏时长除以肾上腺素总剂量。
- 多变量logistic回归校正了年龄、性别、疾病类别、骤停地点、骤停时长、一天中的时段及首次肾上腺素给药时间。
- 现行指南推荐心肺复苏期间每3-5分钟给予肾上腺素,本研究观察到的更长平均间隔与出院生存改善相关。
适用人群与场景
- 儿童院内心搏骤停且符合纳入标准、录入AHA Get With The Guidelines-Resuscitation登记库的1630例患者。
- 次要分析将骤停时正在接受血管活性药物输注的患者与未接受输注者分开。
研究设计与关键结果
- 研究类型为回顾性登记库分析,样本量1630例儿童院内心搏骤停。
- 平均肾上腺素给药间隔按首次肾上腺素后复苏时长除以总剂量计算,分为1-5分钟、>5至<8分钟、8至<10分钟/剂三组。
- 主要终点出院生存:以1-5分钟/剂为参照,全队列>5至<8分钟/剂调整OR 1.81(95%CI 1.26-2.59),8至<10分钟/剂调整OR 2.64(95%CI 1.53-4.55)。
- 未接受血管活性药物输注者:>5至<8分钟/剂调整OR 1.99(95%CI 1.29-3.06),8至<10分钟/剂调整OR 2.67(95%CI 1.14-5.04)。
证据类型、等级与局限
- 证据类型:基于AHA Get With The Guidelines-Resuscitation登记库的回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,儿童院内心搏骤停中长于现行推荐的平均肾上腺素给药间隔与出院生存改善相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Current guidelines recommend epinephrine every 3-5min during cardiopulmonary resuscitation. For adults with in-hospital cardiac arrest (IHCA), longer dosing intervals are associated with improved survival to discharge. This study investigates whether longer epinephrine dosing intervals were associated with improved survival to discharge during pediatric IHCA.
METHODS: Retrospective review of AHA Get With The Guidelines-Resuscitation registry identified 1630 pediatric IHCAs that met inclusion criteria. Average epinephrine dosing interval was defined by dividing duration of resuscitation after first dose of epinephrine by total doses. Average dosing intervals were categorized as 1-5min, >5 to <8min, and 8 to <10min/dose. Primary outcome was survival to hospital discharge. Multivariable logistic regression models controlled for age, gender, illness category, location of arrest, arrest duration, time of day, and time to first epinephrine dose. Secondary analysis separated patients on vasoactive infusion at the time of arrest from those without an infusion in place.
RESULTS: Odds ratios (OR) calculated using 1-5min/dose interval as reference. For the total cohort, adjusted OR for survival to hospital discharge for >5 to <8min was 1.81 (95% CI 1.26-2.59), and 8 to <10min 2.64 (95% CI 1.53-4.55). For patients not receiving vasoactive infusion, adjusted OR for survival to discharge for >5 to <8min was 1.99 (95% CI 1.29-3.06) and 8 to <10min 2.67 (95% CI 1.14-5.04).
CONCLUSIONS: Longer average dosing intervals than currently recommended for epinephrine administration during pediatric IHCA were associated with improved survival to hospital discharge.
参考来源
- Hoyme DB, Patel SS, Samson RA, et al. Epinephrine dosing interval and survival outcomes during pediatric in-hospital cardiac arrest. Resuscitation. 2017. PMID: 28552658. doi:10.1016/j.resuscitation.2017.05.023
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。